ClinicalTrialsFinder

IDH Wild-type and STAT3-positive Glioblastoma Clinical Trials in Catania, Italia/Catania

1 recruitingCatania, Italia/Catania, Italy

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
Istituto Oncologico Veneto IRCCS110 enrolled16 locationsNCT06964815